A report on state‐wide implementation of newborn screening for X‐linked Adrenoleukodystrophy-Reference-Cited by-同舟云学术

A report on state‐wide implementation of newborn screening for X‐linked Adrenoleukodystrophy

Published:2019-05-10 Issue: Volume: Page:
ISSN:1552-4825
Container-title:American Journal of Medical Genetics Part A
language:en
Short-container-title:Am J Med Genet

Author:

Wiens Katie¹^ORCID,Berry Susan A.¹,Choi Hyoung²,Gaviglio Amy³,Gupta Ashish⁴,Hietala Amy³,Kenney‐Jung Daniel²,Lund Troy⁴^ORCID,Miller Weston⁵,Pierpont Elizabeth I.⁶,Raymond Gerald⁷,Winslow Holly³,Zierhut Heather A.⁸^ORCID,Orchard Paul J.⁴

Affiliation:

1. Division of Genetics and Metabolism, Departments of Pediatrics and Genetics, Cell Biology & DevelopmentUniversity of Minnesota Minneapolis MN USA

2. Division of Pediatric Neurology, Department of NeurologyUniversity of Minnesota Minneapolis MN USA

3. Minnesota Department of Health St. Paul MN USA

4. Division of Blood and Marrow Transplantation, Department of PediatricsUniversity of Minnesota Minneapolis MN USA

5. Sangamo Therapeutics, Inc. Brisbane CA USA

6. Division of Clinical Behavioral Neuroscience,Department of PediatricsUniversity of Minnesota Minneapolis MN USA

7. Division of Pediatric Neurology, Department of PediatricsPenn State Health Milton S. Hershey Medical Center Hershey PA USA

8. Department of Genetics, Cell, Biology and DevelopmentUniversity of Minnesota Minneapolis MN USA

Funder

Minnesota Department of Health

Publisher

Wiley

Subject

Genetics(clinical),Genetics

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajmg.a.61171

Reference25 articles.

1. ALD Mutation Database. (2019). Retrieved March 6 2019 fromhttps://adrenoleukodystrophy.info/mutations-and-variants-in-abcd1

2. Adrenoleukodystrophy: Incidence, new mutation rate, and results of extended family screening

3. Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes

4. Elevated plasma adrenocorticotropin concentration as evidence of limited adrenocortical reserve in patients with adrenomyeloneuropathy;Blevins L. S.;Journal of Clinical Endocrinology and Metabolism,1994

5. Caggana M. (2018).Update on X‐ALD screening in the New York Laboratory. Retrieved January 8 2018 fromhttps://www.aidanhasaposse.org/uploads/7/3/6/5/73650801/new_york_ald_nbs_update_michele_caggana_sc.d._facmg.pdf

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma C24:0- and C26:0-lysophosphatidylcholines are Reliable Biomarkers for the Diagnosis of Peroxisomal β-Oxidation Disorders;Journal of Lipid Research;2024-02

2. The Clinical Spectrum of Adrenoleukodystrophy at a Portuguese Tertiary Hospital: Case Series and Review of Literature;Cureus;2024-01-18

3. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population;Clinica Chimica Acta;2024-01

4. Neurologic and Muscular Cases: Progressive Gait Impairment and Genitourinary Dysfunction;Genomics in the Clinic;2024

5. Newborn screening for adrenoleukodystrophy: International experiences and challenges;Molecular Genetics and Metabolism;2023-12